Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Mintzes

Showing results (31-40 of 166) with videos related to

Pageof 17
Sort By:
Drug and Therapeutics Bulletin|October 25, 2023
Semaglutide: a new drug for the treatment of obesityJoel Lexchin, Barbara Mintzes
Journal of General Internal Medicine|February 12, 2020
The "Nuts and Bolts" of Opioid Marketing: Promotional Messages to Family Doctors in Sacramento, Vancouver, Montreal, and ToulouseBarbara Mintzes, Joel Lexchin
Journal of Pharmaceutical Policy and Practice|July 14, 2021
"Drugs to avoid" to improve quality use of medicines: how is Australia faring?Agnes Vitry, Barbara Mintzes
BMJ (Clinical Research Ed.)|October 5, 2022
Radical transparency in post-market oversight of medicine safetyBarbara Mintzes, Colleen Fuller
BMJ (Clinical Research Ed.)|April 12, 2018
The rise of ambiguous competing interest declarationsBarbara Mintzes, Quinn Grundy
BMJ (Clinical Research Ed.)|February 7, 2020
Flawed evidence underpins approval of new cancer drugsBarbara Mintzes, Agnes Vitry
The American Journal of Managed Care|September 10, 2008
Medicine reimbursement recommendations in Canada, Australia, and ScotlandJoel Lexchin, Barbara Mintzes
BMC Pregnancy and Childbirth|July 23, 2014
Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insuranceGillian E Hanley, Barbara Mintzes
The New Zealand Medical Journal|October 29, 2003
Direct-to-consumer advertising is more profitable if it is misleadingPeter R Mansfield, Barbara Mintzes
The Medical Journal of Australia|August 22, 2023
Pharmaceutical company sponsorship of doctors: is gender equity a concern?Barbara Mintzes, David B Menkes
Pageof 17

Showing results (31-40 of 166) with videos related to

Sort By:
Pageof 17
Drug and Therapeutics Bulletin|October 25, 2023
Semaglutide: a new drug for the treatment of obesityJoel Lexchin, Barbara Mintzes
Journal of General Internal Medicine|February 12, 2020
The "Nuts and Bolts" of Opioid Marketing: Promotional Messages to Family Doctors in Sacramento, Vancouver, Montreal, and ToulouseBarbara Mintzes, Joel Lexchin
Journal of Pharmaceutical Policy and Practice|July 14, 2021
"Drugs to avoid" to improve quality use of medicines: how is Australia faring?Agnes Vitry, Barbara Mintzes
BMJ (Clinical Research Ed.)|October 5, 2022
Radical transparency in post-market oversight of medicine safetyBarbara Mintzes, Colleen Fuller
BMJ (Clinical Research Ed.)|April 12, 2018
The rise of ambiguous competing interest declarationsBarbara Mintzes, Quinn Grundy
BMJ (Clinical Research Ed.)|February 7, 2020
Flawed evidence underpins approval of new cancer drugsBarbara Mintzes, Agnes Vitry
The American Journal of Managed Care|September 10, 2008
Medicine reimbursement recommendations in Canada, Australia, and ScotlandJoel Lexchin, Barbara Mintzes
BMC Pregnancy and Childbirth|July 23, 2014
Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insuranceGillian E Hanley, Barbara Mintzes
The New Zealand Medical Journal|October 29, 2003
Direct-to-consumer advertising is more profitable if it is misleadingPeter R Mansfield, Barbara Mintzes
The Medical Journal of Australia|August 22, 2023
Pharmaceutical company sponsorship of doctors: is gender equity a concern?Barbara Mintzes, David B Menkes
Pageof 17